Deep Venous Thrombosis, Pulmonary Embolism, and Inferior Vena Cava Filters

Experts discuss standards of care for outpatient management of these conditions

Feb. 10, 2026 at 1:39pm

Pulmonary embolisms affect 370,000 patients per year and may cause up to 100,000 deaths per year. Patients diagnosed with pulmonary embolism may be managed as an outpatient with direct oral anticoagulant therapy if they have no patient characteristics that place them at higher risk of death. Those with known risk factors require hospital admission and patients with hypotension may require thrombolytic therapy. Injury Care Solutions Group experts are qualified to describe the standards of care for the outpatient management of deep venous thrombosis, pulmonary embolism, and inferior vena cava filters.

Why it matters

Venous thromboembolism, which includes deep vein thrombosis and pulmonary embolism, is a major cause of morbidity and mortality. Understanding the appropriate management of these conditions, including the use of anticoagulants and inferior vena cava filters, is crucial for providing effective patient care.

The details

The American College of Chest Physicians (CHEST) guidelines provide evidence-based recommendations for antithrombotic therapy for venous thromboembolism. Injury Care Solutions Group experts are qualified to describe the standards of care for the outpatient management of deep venous thrombosis, pulmonary embolism, and inferior vena cava filters, including indications for prophylaxis, management of provoked and unprovoked DVT, management of recurrent DVT and PE, and management of IVC filter placement, retrieval, and complications.

  • Pulmonary embolisms affect 370,000 patients per year and may cause up to 100,000 deaths per year.

The players

Injury Care Solutions Group

A group of experts qualified to describe the standards of care for the outpatient management of deep venous thrombosis, pulmonary embolism, and inferior vena cava filters.

American College of Chest Physicians (CHEST)

The organization that provides evidence-based recommendations for antithrombotic therapy for venous thromboembolism.

Greg Vigna, MD, JD

A board-certified PM&R physician and life care planner who can provide more information about the topic.

Got photos? Submit your photos here. ›

What they’re saying

“To learn more, visit our website”

— Greg Vigna, MD, JD, Board Certified PM&R, Life Care Planner

The takeaway

Proper management of venous thromboembolism, including the use of anticoagulants and inferior vena cava filters, is crucial for reducing morbidity and mortality. The Injury Care Solutions Group experts are qualified to provide guidance on the standards of care for these conditions.